tiprankstipranks
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market

Takeda Pharmaceutical Co (TKPHF) Income Statement

Compare
33 Followers

Takeda Pharmaceutical Co Income Statement

Last quarter (Q3 2024), Takeda Pharmaceutical Co's total revenue was ¥1.14T, an increase of 2.96% from the same quarter last year. In Q3, Takeda Pharmaceutical Co's net income was ¥23.79B. See Takeda Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 4.26T¥ 4.03T¥ 3.57T¥ 3.20T¥ 3.29T
Gross Profit
¥ 2.83T¥ 2.78T¥ 2.46T¥ 2.20T¥ 2.20T
Operating Expenses
¥ 2.62T¥ 2.29T¥ 2.00T¥ 1.69T¥ 2.10T
Depreciation and Amortization
¥ 728.00B¥ 664.40B¥ 583.15B¥ 559.67B¥ 583.65B
EBITDA
¥ 874.60B¥ 1.18T¥ 1.18T¥ 983.72B¥ 880.33B
Operating Income
¥ 214.07B¥ 490.50B¥ 460.84B¥ 509.27B¥ 100.41B
Other Income/Expenses
¥ -161.28B¥ -115.42B¥ -158.27B¥ -143.03B¥ -161.16B
Pretax Income
¥ 52.79B¥ 375.09B¥ 302.57B¥ 366.24B¥ -60.75B
Net Income
¥ 144.07B¥ 317.02B¥ 230.06B¥ 376.00B¥ 44.24B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 92.09¥ 204.29¥ 147.14¥ 240.72¥ 28.41
Diluted EPS
¥ 91.16¥ 201.94¥ 145.87¥ 238.96¥ 28.25
Weighted Average Shares Outstanding
1.56B 1.55B 1.56B 1.56B 1.56B
Weighted Average Shares Outstanding (Diluted)
1.58B 1.57B 1.58B 1.57B 1.57B
Currency in JPY

Takeda Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis